Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Diovan (valsartan): Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Diovan (valsartan) - General Information

Valsartan (trade name Valsartan) is an angiotensin II receptor antagonist, acting on the AT1 subtype. In the U.S., valsartan is indicated for treatment of high blood pressure, of congestive heart failure (CHF), and post-myocardial infarction (MI). In 2005, Valsartan was prescribed more than 12 million times in the United States.

 

Diovan (valsartan) for patients

 

Diovan (valsartan) Interactions

No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. The valsartan-atenolol combination was more antihypertensive than either component, but it did not lower the heart rate more than atenolol alone.

Coadministration of valsartan and warfarin did not change the pharmacokinetics of valsartan or the time-course of the anticoagulant properties of warfarin.

CYP 450 Interactions: The enzyme(s) responsible for valsartan metabolism have not been identified but do not seem to be CYP 450 isozymes. The inhibitory or induction potential of valsartan on CYP 450 is also unknown.

As with other drugs that block angiotensin II or its effects, concomitant use of potassium sparing diuretics (e.g. spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine.

 

Diovan (valsartan) Contraindications

Valsartan (valsartan) is contraindicated in patients who are hypersensitive to any component of this product.

 

Additional information about Diovan (valsartan)

Valsartan Indication: For the treatment of hypertension. Mechanism Of Action: Valsartan competes with angiotensin II for binding at the AT1 receptor subtype. As angiotensin II is a vasoconstrictor which also stimulates the synthesis and release of aldosterone, blockage of its effects results in a decreases in systemic vascular resistance. Drug Interactions: Not Available Food Interactions: Not Available Generic Name: Valsartan Synonyms: Not Available Drug Category: Antihypertensive Agents; Angiotensin II Receptor Antagonists Drug Type: Small Molecule; Approved; Investigational Absorption: Not Available Toxicity (Overdose): Not Available Protein Binding: 95% Biotransformation: Not Available Half Life: 6 hours Dosage Forms of Valsartan: Tablet OralCapsule Oral Chemical IUPAC Name: (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid Chemical Formula: C24H29N5O3 Valsartan on Wikipedia: https://en.wikipedia.org/wiki/Valsartan Organisms Affected: Humans and other mammals